Artificial intelligence continues to push boundaries in biotechnology. An AI model trained on UK Biobank data can predict the risk and timing of over 1,000 diseases up to 20 years in advance, representing a transformative advancement for personalized medicine. Additionally, researchers from Stanford and the Arc Institute have developed AI-designed bacteriophage genomes, successfully generating functional viruses that lyse bacteria, opening new avenues for combating antibiotic resistance. These developments underscore AI's growing role in biomedical research and therapeutic innovation.